Back

Circulating miRNAs expression in atrial fibrillation patients candidates to transcatheter ablation

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Basic Science Genetic Causes of Atrial Fibrillation EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Alessio Galli

Heart Rhythm Management Centre, Brussels (Belgium)

5 More presentations in this session

Presentation thumbnail
Plasminogen activator inhibitor-1 as a predictor of recurrence atrial fibrillation after radiofrequency catheter ablation of pulmonary veins
Doctor R. Rekvava (Tbilisi, GE)
Abstract Slides
Presentation thumbnail
In-vivo and cellular left atrial function in an experimental model of heart failure with preserved ejection fraction
Professor F. Hohendanner (Berlin, DE)
Abstract
Presentation thumbnail
digoxin and platelet activation in atrial fibrillation patients.
Professor P. Pignatelli Spinazzola (Rome, IT)
Abstract
Presentation thumbnail
Ivabradine-induced atrial tachyarrhythmias in healthy rats
Mr B. Finascu (Tirgu Mures, RO)
Abstract
Presentation thumbnail
The metabolic modulator trimetazidine inhibits AF-induced atrial structural remodelling
Mr D. Opacic (Maastricht, NL)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Basic Science

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources